-
-
-
-
-
-
-
MiMedx Group (MDXG) PT Lowered to $7 at Citizens Amid Reimbursement Disruption
-
-
-
-
-
-
-
MIMEDX study published on tissue allograft immunomodulatory effects
-
-
-
-
-
-
-
MIMEDX supports proposed Medicare skin substitute reimbursement changes
-
-
-
-
-
-
-
MiMedx Group (MDXG) Tops Q4 EPS by 1c
-
-
-
-
-
-
-
Cantor Fitzgerald Starts MiMedx Group (MDXG) at Overweight
-
448,164 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

